| Experimental therapy of human glioma by means of a genetically engineered virus mutant RL Martuza, A Malick, JM Markert, KL Ruffner, DM Coen Science 252 (5007), 854-856, 1991 | 1231 | 1991 |
| Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial JM Markert, MD Medlock, SD Rabkin, GY Gillespie, T Todo, WD Hunter, ... Gene therapy 7 (10), 867-874, 2000 | 1177 | 2000 |
| A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant … EA Chiocca, KM Abbed, S Tatter, DN Louis, FH Hochberg, F Barker, ... Molecular Therapy 10 (5), 958-966, 2004 | 522 | 2004 |
| Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM JM Markert, PG Liechty, W Wang, S Gaston, E Braz, M Karrasch, ... Molecular Therapy 17 (1), 199-207, 2009 | 434 | 2009 |
| Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors JN Parker, GY Gillespie, CE Love, S Randall, RJ Whitley, JM Markert Proceedings of the National Academy of Sciences 97 (5), 2208-2213, 2000 | 394 | 2000 |
| A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas P Forsyth, G Roldán, D George, C Wallace, CA Palmer, D Morris, ... Molecular Therapy 16 (3), 627-632, 2008 | 301 | 2008 |
| Differential gene expression profiling in human brain tumors JM MARKERT, CM FULLER, GY GILLESPIE, JK BUBIEN, LEEA McLEAN, ... Physiological genomics 5 (1), 21-33, 2001 | 300 | 2001 |
| Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins S Andreansky, B He, J Van Cott, J McGhee, JM Markert, GY Gillespie, ... Gene therapy 5 (1), 121-130, 1998 | 299 | 1998 |
| A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses JM Markert, SN Razdan, HC Kuo, A Cantor, A Knoll, M Karrasch, ... Molecular Therapy 22 (5), 1048-1055, 2014 | 289 | 2014 |
| The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. SS Andreansky, B He, GY Gillespie, L Soroceanu, J Markert, J Chou, ... Proceedings of the National Academy of Sciences 93 (21), 11313-11318, 1996 | 260 | 1996 |
| Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas GK Friedman, JM Johnston, AK Bag, JD Bernstock, R Li, I Aban, ... New England Journal of Medicine 384 (17), 1613-1622, 2021 | 216 | 2021 |
| Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors S Andreansky, L Soroceanu, ER Flotte, J Chou, JM Markert, GY Gillespie, ... Cancer research 57 (8), 1502-1509, 1997 | 210 | 1997 |
| A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma PY Wen, DA Reardon, TS Armstrong, S Phuphanich, RD Aiken, ... Clinical Cancer Research 25 (19), 5799-5807, 2019 | 207 | 2019 |
| Phenotypic plasticity of invasive edge glioma stem-like cells in response to ionizing radiation M Minata, A Audia, J Shi, S Lu, J Bernstock, MS Pavlyukov, A Das, ... Cell reports 26 (7), 1893-1905. e7, 2019 | 206 | 2019 |
| Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastases EM Thomas, RA Popple, X Wu, GM Clark, JM Markert, BL Guthrie, Y Yuan, ... Neurosurgery 75 (4), 409-418, 2014 | 205 | 2014 |
| Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir JM Markert, A Malick, DM Coen, RL Martuza Neurosurgery 32 (4), 597-603, 1993 | 202 | 1993 |
| Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria: A case series BE Pearson, JM Markert, WS Fisher, BL Guthrie, JB Fiveash, CA Palmer, ... Neurosurgical focus 24 (5), E3, 2008 | 198 | 2008 |
| Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain CR Oliva, SE Nozell, A Diers, SG McClugage, JN Sarkaria, JM Markert, ... Journal of Biological Chemistry 285 (51), 39759-39767, 2010 | 194 | 2010 |
| Plan quality and treatment planning technique for single isocenter cranial radiosurgery with volumetric modulated arc therapy GM Clark, RA Popple, BM Prendergast, SA Spencer, EM Thomas, ... Practical radiation oncology 2 (4), 306-313, 2012 | 170 | 2012 |
| Acid-sensing ion channels in malignant gliomas BK Berdiev, J Xia, LA McLean, JM Markert, GY Gillespie, TB Mapstone, ... Journal of Biological Chemistry 278 (17), 15023-15034, 2003 | 170 | 2003 |
G Yancey GillespieProfessor Emeritus of Neurosurgery, University of Alabama at BirminghamVerified email at uabmc.edu
